Avantor Inc (AVTR)
20.70
+0.34
(+1.67%)
USD |
NYSE |
Nov 22, 11:23
Avantor Debt to Equity Ratio: 0.8862 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.8862 |
| June 30, 2024 | 0.9411 |
| March 31, 2024 | 0.9975 |
| December 31, 2023 | 1.054 |
| September 30, 2023 | 1.103 |
| June 30, 2023 | 1.174 |
| March 31, 2023 | 1.214 |
| December 31, 2022 | 1.295 |
| September 30, 2022 | 1.348 |
| June 30, 2022 | 1.463 |
| March 31, 2022 | 1.574 |
| December 31, 2021 | 1.673 |
| Date | Value |
|---|---|
| September 30, 2021 | 1.361 |
| June 30, 2021 | 1.893 |
| March 31, 2021 | 1.651 |
| December 31, 2020 | 1.83 |
| September 30, 2020 | 1.987 |
| June 30, 2020 | 1.999 |
| March 31, 2020 | 2.072 |
| December 31, 2019 | 2.078 |
| September 30, 2019 | 2.178 |
| June 30, 2019 | 2.208 |
| March 31, 2019 | -2.164 |
| December 31, 2018 | -2.269 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.8862
Minimum
Sep 2024
2.078
Maximum
Dec 2019
1.480
Average
1.412
Median
Debt to Equity Ratio Benchmarks
| Bruker Corp | 1.271 |
| Azenta Inc | 0.00 |
| Harvard Bioscience Inc | 0.5796 |
| Bionano Genomics Inc | 0.306 |
| Akoya Biosciences Inc | 5.568 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 12.84B |
| Total Liabilities (Quarterly) | 7.287B |
| Shareholders Equity (Quarterly) | 5.553B |
| Current Ratio | 1.537 |
| Net Debt Paydown Yield | 1.09% |